https://www.oncologynurseadvisor.com Tue, 25 Feb 2020 15:54:02 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/de-escalation-from-beacopp-to-abvd-may-be-most-cost-effective-hl-treatment-option/ Tue, 25 Feb 2020 15:54:00 +0000 https://www.oncologynurseadvisor.com/?p=76561 Of 5 treatment regimens assessed, a PET-adapted de-escalation treatment approach was found to be the most cost-effective in 87% of cases modelled. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/eliciting-t-cell-response-in-multiple-myeloma-and-developing-personalize-vaccines-with-neoantigens/ Mon, 27 Jan 2020 15:04:04 +0000 https://www.oncologynurseadvisor.com/?p=72206 Neoantigens may have the ability to provoke the immune system into recognizing and killing cancer cells in patients with multiple myeloma.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/poorer-survival-outcomes-for-patients-with-vitamin-d-deficiency-prior-to-treatment/ Wed, 27 Nov 2019 19:25:01 +0000 https://www.oncologynurseadvisor.com/?p=70244 Patients with Hodgkin lymphoma who were deficient for vitamin D experienced reduced progression-free and overall survival.]]> https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/event-simulation-model-to-analyze-effect-of-wait-times-on-car-t-therapy-efficacy/ Tue, 26 Nov 2019 15:00:31 +0000 https://www.oncologynurseadvisor.com/?p=70155 Researchers created a discrete event simulation model to assess the potential influence of wait time ranging from 1 to 9 months on CAR-T therapy efficacy. ]]>